PBYI Beats Q3 Earnings & Revenue Estimates, Revises '24 View, Stock Up

Puma Biotechnology, Inc. (PBYI) reported third-quarter 2024 adjusted earnings of 45 cents per share, which beat the Zacks Consensus Estimate of 35 cents. In the year-ago quarter, the company had reported adjusted earnings of 17 cents per share.The above-adjusted earnings exclude the impact of stock-based compensation expense. Including the same, the reported earnings per share were 41 cents in the third quarter of 2024 compared with earnings of 12 cents reported in the year-ago quarter.In the third quarter, ...